Abbott Class Action: Levi & Korsinsky Reminds Abbott Laboratories Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of October 31, 2022 - ABTNewsfile Corp • 10/20/22
Abbott's (ABT) Q3 Earnings Top Estimates, 2022 EPS View Up (Revised)Zacks Investment Research • 10/20/22
FILING DEADLINE--Kuznicki Law PLLC Announces Class Action on Behalf of Shareholders of Abbott Laboratories - ABTPRNewsWire • 10/20/22
Abbott Labs Reports Narrower-Than-Expected Quarterly Declines, And Shares ToppleInvestors Business Daily • 10/19/22
Abbott attributes Q3 sales decline to baby formula shortage, less COVID-19 testingMarket Watch • 10/19/22
Abbott is recalling baby formula again after discovering faulty bottle caps on Similac products produced at Ohio facilityBusiness Insider • 10/15/22
ROSEN, SKILLED INVESTOR COUNSEL, Encourages Abbott Laboratories Investors With Losses to Secure Counsel Before Important October 31 Deadline in Securities Class Action - ABTPRNewsWire • 10/15/22
ABBOTT LABORATORIES SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Reminds Investors with Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Abbott Laboratories - ABTPRNewsWire • 10/15/22